Brewin Dolphin LTD Novavax Inc Transaction History

Brewin Dolphin LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2023	BUY	$177.8 - $270.58 $57,785 - $87,938	325 Added 20.17%	1,936 $401 Million
Q1 2021 Nov 09, 2023	BUY	$112.98 - $319.93 $162,691 - $460,699	1,440 Added 842.11%	1,611 $292 Million
Q4 2020 Nov 09, 2023	SELL	$78.74 - $139.5 $16,535 - $29,295	-210 Reduced 55.12%	171 $19.1 Million
Q3 2020 Nov 09, 2023	BUY	$79.44 - $178.51 $28,280 - $63,549	356 Added 1424.0%	381 $41.3 Million
Q2 2020 Nov 09, 2023	SELL	$13.86 - $83.61 $1,926 - $11,621	-139 Reduced 84.76%	25 $2.08 Million
Q2 2019 Nov 09, 2023	BUY	$4.93 - $12.2 $808 - $2,000	164 New	164 $961,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

Stay updated on Brewin Dolphin LTD with notifications on news.